L’Oréal and Evonik acquire minority stakes in Abolis Biotechnologies

L’Oréal and Evonik have announced a joint investment in the biotechnology company Abolis, which specializes in the manufacture of ingredients derived from microorganisms for the cosmetics, pharmaceutical and nutrition markets. The beauty giant and the manufacturer of specialty chemical ingredients…









